Related Experiment Video

Updated: May 14, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

[Progressive multifocal leukoencephalopathy (review)]

M N Zakharova

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |February 5, 2013
    PubMed

    Insights

    Progressive multifocal leukoencephalopathy (PME) is a fatal CNS demyelinating disease often occurring during immunosuppression. This study reviews PME

    Area of Science:

    • Neuroimmunology
    • Neurology
    • Infectious Diseases

    Background:

    • Progressive multifocal leukoencephalopathy (PME) is a severe demyelinating disease of the central nervous system (CNS).
    • PME is an opportunistic infection linked to immunosuppression from chronic illnesses or treatments.
    • The condition is frequently fatal, highlighting the need for better understanding and management.

    Purpose of the Study:

    • To explore the underlying mechanisms of PME development.
    • To discuss current diagnostic strategies for PME.
    • To review existing and potential therapeutic interventions for PME.

    Main Methods:

    • Literature review of PME pathogenesis.
    • Analysis of diagnostic criteria and imaging findings for PME.
    • Examination of treatment options for PME, including antiviral and immunomodulatory therapies.

    Main Results:

    • PME pathogenesis involves reactivation of the JC virus in oligodendrocytes.
    • Diagnosis relies on clinical presentation, MRI findings, and cerebrospinal fluid analysis.
    • Treatment options are limited, with focus on managing immunosuppression and supportive care.

    Conclusions:

    • PME remains a significant challenge in immunocompromised individuals.
    • Further research into PME mechanisms and novel therapies is crucial.
    • Improved diagnostic and treatment protocols are needed to improve patient outcomes.

    More Related Videos

    Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis26:48

    Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

    Published on: July 4, 2007

    Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo10:50

    Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

    Published on: March 26, 2019

    Related Concept Videos

    Encephalitis ll: Pathophysiology01:26

    Encephalitis ll: Pathophysiology

    Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
    Encephalitis l: Introduction01:19

    Encephalitis l: Introduction

    Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
    Cerebral Edema ll: Pathophysiology01:22

    Cerebral Edema ll: Pathophysiology

    Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Arboviral Encephalitis01:25

    Arboviral Encephalitis

    Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...